GRCE Earnings

Quarterly EPS
$-0.36
Q3 2025
$0.04
Q4 2025
$-0.21
Q1 2026
$-0.06
Q2 2026
$-0.14
Q3 2026
$-0.07
Q4 2026
$-0.91
Q1 2027
Latest RevenueN/A
Latest Net Income-15790000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$0.910-15790000-333.3%
Q4 2026-$0.070-1178000-275.0%
Q3 2026-$0.140-2315000+61.1%
Q2 2026-$0.060-938000
Q1 2026-$0.210-3362000
Q4 2025$0.040636.0K
Q3 2025-$0.360-4155000
Grace Therapeutics (GRCE) — Earnings